Healthcare services and information technology company $MCK said it has completed the previously announced acquisitions of Vantage Oncology, LLC, and Biologics, Inc., for a combined purchase price of about $1.2Bil.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.
$TSTR's average loans were up 4.3% in 1Q17 over 1Q16. Average
deposits were up 1.8% over the same period a year earlier. For 1Q17, return on
average assets and return on average equity were 0.91% and 10.17%,
respectively, compared to 0.89% and 9.98% for 1Q16.
$TSTR reported a 5.2% increase in 1Q17 earnings. Net income was
$10.9MM or $0.114 per share compared to $10.4MM or $0.109 per share in 1Q16. Net
interest income was $37.4MM compared to $36.1MM in 1Q16.
$MAN sees good opportunities for its Solutions business in the US,
as well as in permanent placement. $MAN has been applying strong pricing discipline
and has been careful in terms of acquiring businesses and segmenting its
business. Despite revenue declines, client segmentation and pricing discipline
have helped in gross profit expansion.
$BEL announced the nomination of a new independent director, Demetra Pinsent, CEO of Charlotte Tilbury Beauty Ltd., for election to its board of directors at the company’s 2017 AGM to be held on June 1, 2017.
$MAN is starting to see some companies make decisions in
anticipation of a different business environment and this could partly be related
to Brexit. The company added that the UK market is getting softer in a number
of areas and $MAN is starting to see its clients react to this situation.